News

FDA issues highest risk warning after mushrooms recalled nationwide
The Class I recall status indicates that the product poses a risk of causing serious health consequences or death if consumed ...
Coffee pods recall triggers lowest-risk warning from FDA
A production issue raised concerns that ink printing on some cups could run when exposed to high temperatures, inspectors ...
GSK's Blood Cancer Drug Faces US Setback Due To FDA Panel's Eye Safety Warning
Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of GSK plc’s ...
Soy Carmín on MSN9h
Minor Alert: Coffee Pods Recalled Over Ink Concerns, FDA Issues Lowest-Risk Warning
Your morning coffee ritual is usually a simple pleasure, but a recent recall of certain coffee pods might make you ...
FDA Issues Risk Warning for Sunscreen Recall in Multiple States
Class II recalls from the FDA indicate a potential risk to consumer safety where use or exposure to the product may cause ...
Nationwide Sausage Recall as Consumer Warning Issued
Kayem Foods Inc. has issued a voluntary recall for more than 24,000 pounds of its Sweet Apple Chicken Sausages.
National Consumer Alert on 7-OH Products Posing Significant Dangers
FDA issues warning letters to distributors of food, dietary supplements and unapproved drugs that contain ...
Gene therapy maker Sarepta tells FDA it won't halt shipments despite patient deaths
Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of its gene ...
MediaNama10d
FSSAI: E-Commerce Platforms Could Face Severe Action Over Food Safety Non-Compliance
FSSAI warns e-commerce platforms to comply with food safety rules or face action, citing violations in dark stores and poor ...
Devdiscourse15h
Scrutiny Intensified: FDA Calls Halt on Sarepta's Gene Therapy Amid Safety Concerns
The FDA asked Sarepta Therapeutics to halt shipments of its Elevidys gene therapy after a patient's death linked to a similar treatment. Sarepta will continue shipments for ambulatory patients but ...
Sarepta tells FDA it won’t halt shipments despite patient deaths
In a highly unusual move, Cambridge-based Sarepta said late Friday won’t comply with a request from the Food and Drug Administration to halt all shipments of its gene therapy.
Fake weight loss drugs spark alarm: Urgent warning sent to FDA over counterfeit GLP-1s
New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.